Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects

Lucy Eletel1, Talia Thomas1, Emily A Berry1

  • 1Department of Medical Education, Anne Marion Burnett School of Medicine at Texas Christian University, Fort Worth, TX, USA.

Paediatric Drugs
|March 21, 2025
PubMed

Insights

Fungal infections in neonates are serious threats. Early diagnosis and appropriate antifungal treatment are vital, especially for preterm infants, to prevent severe outcomes.

Area of Science:

  • Neonatal Medicine
  • Mycology
  • Infectious Diseases

Background:

  • Fungal infections pose significant life-threatening risks to neonates, particularly preterm infants with immature immune systems.
  • Candida albicans is the primary fungal pathogen, causing a spectrum of disease from superficial rashes to systemic infections like sepsis and meningitis.
  • Congenital cutaneous candidiasis can lead to disseminated infections with high mortality.

Purpose of the Study:

  • To review the diagnosis, treatment, and prevention of fungal infections in neonates.
  • To highlight the challenges in early diagnosis and the importance of accurate organism identification for targeted antifungal therapy.
  • To provide pharmacologic and dosing information for key antifungal agents used in neonatal care.

Main Methods:

  • Review of major antifungal agents including amphotericin B, echinocandins, and azoles.
  • Discussion of pharmacologic properties and neonatal dosing considerations.
  • Emphasis on preventive strategies such as aseptic techniques and clinical monitoring.

Main Results:

  • Candida species are the most common cause of neonatal fungal infections, requiring species-specific treatment due to varying susceptibilities.
  • Aspergillus and Malassezia are other significant pathogens, with Malassezia often associated with catheter-related fungemia in preterm infants.
  • Information on clinical pharmacology of antifungals in neonates is limited, necessitating careful drug selection and dosing.

Conclusions:

  • Accurate identification of fungal pathogens is crucial for effective treatment of neonatal fungal infections.
  • Antifungal drug selection and dosing in neonates require careful consideration due to limited pharmacokinetic data.
  • Stringent aseptic techniques and vigilant clinical monitoring are essential for preventing and managing neonatal fungal infections.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...